TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue

Monikongkona Boruah, Riyaz Ahmad Mir, Sameer Rastogi, Kapil Sikka, Shipra Agarwal
Clinical Immunology · Elsevier · DOI: 10.1016/j.clim.2026.110761

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles